|
THOC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.123800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.728200E-01 |
| Normal-vs-Stage2 |
3.884000E-01 |
| Normal-vs-Stage3 |
4.097300E-03 |
| Normal-vs-Stage4 |
1.355840E-01 |
| Stage1-vs-Stage2 |
6.529400E-01 |
| Stage1-vs-Stage3 |
8.419000E-04 |
| Stage1-vs-Stage4 |
1.821240E-01 |
| Stage2-vs-Stage3 |
7.077600E-02 |
| Stage2-vs-Stage4 |
1.950170E-01 |
| Stage3-vs-Stage4 |
9.911400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.519200E-01 |
| Normal-vs-AfricanAmerican |
2.336200E-01 |
| Normal-vs-Asian |
3.50350000000166E-06 |
| Caucasian-vs-AfricanAmerican |
9.768400E-01 |
| Caucasian-vs-Asian |
1.842410E-04 |
| AfricanAmerican-vs-Asian |
4.240600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.113600E-01 |
| Normal-vs-Female |
2.709800E-02 |
| Male-vs-Female |
1.203210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.386800E-01 |
| Normal-vs-Extreme_Weight |
5.944600E-01 |
| Normal-vs-Obese |
1.805250E-01 |
| Normal-vs-Extreme_Obese |
8.795000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.469000E-01 |
| Normal_Weight-vs-Obese |
9.915200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.232600E-01 |
| Extreme_Weight-vs-Obese |
3.541000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.440600E-01 |
| Obese-vs-Extreme_Obese |
3.248000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.341570E-01 |
| Normal-vs-Age(41-60Yrs) |
5.896100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.502600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.615600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.723800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.205800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.184800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.553000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.024400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.424200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.135400E-01 |
| Normal-VS-Type2 PRCC |
4.576100E-02 |
| Normal-VS-KIRP CIMP |
4.064600E-03 |
| Normal-VS-Unclassified PRCC |
1.401800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.182400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.360700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.994960E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.519620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.413200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.659200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.637810E-01 |
| Normal-vs-N1 |
1.822670E-03 |
| Normal-vs-N2 |
2.790600E-01 |
| N0-vs-N1 |
7.338600E-03 |
| N0-vs-N2 |
7.706800E-01 |
| N1-vs-N2 |
3.953600E-01 |
|
|
